236 related articles for article (PubMed ID: 25139279)
21. Thiolated chitosans: useful excipients for oral drug delivery.
Werle M; Bernkop-Schnürch A
J Pharm Pharmacol; 2008 Mar; 60(3):273-81. PubMed ID: 18284806
[TBL] [Abstract][Full Text] [Related]
22. Mercaptonicotinic acid activated thiolated chitosan (MNA-TG-chitosan) to enable peptide oral delivery by opening cell tight junctions and enhancing transepithelial transport.
Pratap-Singh A; Guo Y; Baldelli A; Singh A
Sci Rep; 2023 Oct; 13(1):17343. PubMed ID: 37833426
[TBL] [Abstract][Full Text] [Related]
23. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316
[TBL] [Abstract][Full Text] [Related]
24. Thiomers: potential excipients for non-invasive peptide delivery systems.
Bernkop-Schnürch A; Krauland AH; Leitner VM; Palmberger T
Eur J Pharm Biopharm; 2004 Sep; 58(2):253-63. PubMed ID: 15296953
[TBL] [Abstract][Full Text] [Related]
25. S-protected thiolated hydroxyethyl cellulose (HEC): Novel mucoadhesive excipient with improved stability.
Leonaviciute G; Bonengel S; Mahmood A; Ahmad Idrees M; Bernkop-Schnürch A
Carbohydr Polym; 2016 Jun; 144():514-21. PubMed ID: 27083843
[TBL] [Abstract][Full Text] [Related]
26. Preactivated thiomers: evaluation of gastroretentive minitablets.
Hauptstein S; Müller C; Dünnhaupt S; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2013 Nov; 456(2):473-9. PubMed ID: 23999225
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro evaluation of a novel thiolated chitosan.
Kafedjiiski K; Krauland AH; Hoffer MH; Bernkop-Schnürch A
Biomaterials; 2005 Mar; 26(7):819-26. PubMed ID: 15350788
[TBL] [Abstract][Full Text] [Related]
28. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
[TBL] [Abstract][Full Text] [Related]
29. Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral delivery of insulin in vivo.
Sudhakar S; Chandran SV; Selvamurugan N; Nazeer RA
Int J Biol Macromol; 2020 May; 150():281-288. PubMed ID: 32057846
[TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of intravesical mucoadhesive self-emulsifying drug delivery systems.
Lupo N; Jalil A; Nazir I; Gust R; Bernkop-Schnürch A
Int J Pharm; 2019 Jun; 564():180-187. PubMed ID: 30981873
[TBL] [Abstract][Full Text] [Related]
31. Comparative in vivo mucoadhesion studies of thiomer formulations using magnetic resonance imaging and fluorescence detection.
Albrecht K; Greindl M; Kremser C; Wolf C; Debbage P; Bernkop-Schnürch A
J Control Release; 2006 Sep; 115(1):78-84. PubMed ID: 16901569
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro characterization of entirely S-protected thiolated pectin for drug delivery.
Hintzen F; Hauptstein S; Perera G; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1266-73. PubMed ID: 24095893
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of functional characteristics of preactivated thiolated chitosan as potential therapeutic agent for dry mouth syndrome.
Laffleur F; Fischer A; Schmutzler M; Hintzen F; Bernkop-Schnürch A
Acta Biomater; 2015 Jul; 21():123-31. PubMed ID: 25900442
[TBL] [Abstract][Full Text] [Related]
34. Preactivated thiolated poly(methacrylic acid-co-ethyl acrylate): synthesis and evaluation of mucoadhesive potential.
Hauptstein S; Bonengel S; Rohrer J; Bernkop-Schnürch A
Eur J Pharm Sci; 2014 Oct; 63():132-9. PubMed ID: 25019181
[TBL] [Abstract][Full Text] [Related]
35. Preactivated thiomers for vaginal drug delivery vehicles.
Friedl HE; Dünnhaupt S; Waldner C; Bernkop-Schnürch A
Biomaterials; 2013 Oct; 34(32):7811-8. PubMed ID: 23886732
[TBL] [Abstract][Full Text] [Related]
36. Three generations of thiolated cyclodextrins: A direct comparison of their mucus permeating and mucoadhesive properties.
Haddadzadegan S; Knoll P; Wibel R; Kali G; Bernkop-Schnürch A
Acta Biomater; 2023 Sep; 167():309-320. PubMed ID: 37271247
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous Effect of Thiolation and Carboxylation of Chitosan Particles Towards Mucoadhesive Oral Insulin Delivery Applications: An In Vitro and In Vivo Evaluation.
Rekha MR; Sharma CP
J Biomed Nanotechnol; 2015 Jan; 11(1):165-76. PubMed ID: 26301311
[TBL] [Abstract][Full Text] [Related]
38. Nasal drug delivery: Design of a novel mucoadhesive and in situ gelling polymer.
Menzel C; Jelkmann M; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2017 Jan; 517(1-2):196-202. PubMed ID: 27890621
[TBL] [Abstract][Full Text] [Related]
39. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
40. Matrix tablets based on thiolated poly(acrylic acid): pH-dependent variation in disintegration and mucoadhesion.
Guggi D; Marschütz MK; Bernkop-Schnürch A
Int J Pharm; 2004 Apr; 274(1-2):97-105. PubMed ID: 15072786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
